Moreover, the pooled transcript levels of MuRF1, another relevant pro-atrophic ubiquitin E3-ligase, were unaffected by PDAC as well but tended to be higher with HH treatment in the WT and the CA group (Table 3). This evidence concerns the gene TRIM63 and cancer.